| PERIOD ENDING | 5-Mar-09 | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 65,263 | 65,263 | 76,150 | | Cost of Revenue | 25,950 | 25,950 | 29,347 | | | Gross Profit | 39,313 | 39,313 | 46,803 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 17,293 | 17,293 | 16,492 | | Non Recurring |
-
|
-
|
-
| | Others | 7,481 | 7,481 | 2,462 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 14,539 | 14,539 | 27,849 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 14,539 | 14,539 | 27,849 | | Interest Expense | 7,553 | 7,553 | 8,829 | | Income Before Tax | 6,986 | 6,986 | 19,020 | | Income Tax Expense | 2,873 | 2,873 | 7,909 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,113 | 4,113 | 11,111 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 4,113 | 4,113 | 11,111 | | Preferred Stock And Other Adjustments | (194) | (194) |
-
| | | Net Income Applicable To Common Shares | $3,919 | $3,919 | $11,111 |
|
0.22% Nasdaq 
Income Statement
